GemCap Biotech ApS: Financial statements 2021
CVR: 38189174
GemCap Biotech ApS (CVR 38189174) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK 6,750. The solvency ratio was 100%.
- Profit/Loss
- 0 kr.
- Equity
- 6,750 kr.
- Total Assets
- 6,750 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | 0 | 7 t. | - |
| 2020 | - | - | 0 | 7 t. | - |
| 2019 | - | - | 0 | 7 t. | - |
| 2018 | - | - | 0 | 7 t. | - |
Find more companies like GemCap Biotech ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
GemCap Biotech ApS has published its annual report for 2020. The net result was DKK 0.
About GemCap Biotech ApS
GemCap Biotech ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2016 and dissolved in 2024. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. In 2023, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK 27,000.
